0.95Open0.60Pre Close13 Volume658 Open Interest8.00Strike Price1.03KTurnover96.89%IV2.84%PremiumDec 20, 2024Expiry Date0.46Intrinsic Value100Multiplier6DDays to Expiry0.24Extrinsic Value100Contract SizeAmericanOptions Type0.7002Delta0.3369Gamma12.53Leverage Ratio-0.0328Theta0.0008Rho8.78Eff Leverage0.0037Vega
Anavex Life Sciences Stock Discussion
$Sunshine Biopharma (SBFM.US)$
$Rumble (RUM.US)$
Got a few superbouncy balls this evening.
making me dizzy 🤣
Anavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer’s Disease Data at J.P. Morgan 2025 Healthcare Conference
Anavex Life Sciences (Nasdaq: AVXL) announced it will present new long-term data from the Phase IIb/III ATTENTION-AD Open-Label-Extension (OLE) trial for blarcamesine in early Alzheimer's disease at the J.P. Morgan 2025 Healthcare Conference. The presentation will showcase data from up to 144 weeks of continuous treatm...
hmmmmm 🤔 looks very similar throughout the market starting at 3 pm
No comment yet